Balance Training Following Pulmonary Rehabilitation on Balance in People With Chronic Obstructive Pulmonary Disease (COPD)

NCT07750821 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2026-08-14

No results posted yet for this study

Summary

This study aims to see if a co-designed balance training programme called Sport4Steadiness (S4S), is acceptable to people with COPD and if the study procedures, including recruitment and the collection of outcomes, is feasible.

Conditions

  • COPD (Chronic Obstructive Pulmonary Disease)
  • COPD
  • Balance Exercise
  • Falls, Intervention
  • Balance Training
  • Pulmonary Rehabilitation

Interventions

OTHER

Sport4Steadiness

Sport4Steadiness (S4S), is a group, exercise based, balance training programme. It was designed by researchers interested in balance in people with COPD and patients and members of the public who have, or care for someone with, COPD or other lung conditions. It adapts parts of different sports, games and activities to train balance and have fun. S4S sessions take place twice a week for 6 weeks, 12 sessions in total. Each session lasts for 2 hours with 1 hour of activity and 1 hour of socialisation

Sponsors & Collaborators

  • North Tees and Hartlepool NHS Foundation Trust

    collaborator OTHER
  • South Tees Hospitals NHS Foundation Trust

    collaborator OTHER
  • Samantha Harrison

    lead OTHER

Principal Investigators

  • Samantha Harrison, Professor · Teesside University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-27
Primary Completion
2027-05-01
Completion
2027-05-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07750821 on ClinicalTrials.gov